Loading clinical trials...
Loading clinical trials...
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Conditions
Interventions
Tenecteplase
Antiplatelet treatment
Locations
61
Australia
Calvary Public Hospital Bruce
Canberra, Australian Capital Territory, Australia
John Hunter Hospital
Newcastle, New South Wales, Australia
Gold Coast University Hospital
Gold Coast, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Box Hill Hospital
Box Hill, Victoria, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
Start Date
April 1, 2015
Primary Completion Date
January 19, 2024
Completion Date
April 10, 2024
Last Updated
January 31, 2025
NCT06658197
NCT02879123
NCT05338697
NCT06075628
NCT06094478
NCT06157502
Lead Sponsor
University of Calgary
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions